Results 101 to 110 of about 5,984 (245)

Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant

open access: yesAmerican Journal of Medical Genetics Part A, Volume 194, Issue 7, July 2024.
Abstract The Undiagnosed Disease Network (UDN) is comprised of clinical and research experts collaborating to diagnose rare disease. The UDN is funded by the National Institutes of Health and includes 12 different clinical sites (About Us, 2022).
Kimberly M. Ezell   +259 more
wiley   +1 more source

Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. [PDF]

open access: yes, 2011
Paroxysmal non-kinesigenic dyskinesia (PNKD) is a rare autosomal dominant movement disorder triggered by stress, fatigue or consumption of either alcohol or caffeine.
Babbitt, Patricia   +6 more
core   +2 more sources

Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant

open access: yesMovement Disorders Clinical Practice, Volume 11, Issue 6, Page 708-715, June 2024.
Abstract Background Genetic syndromes of hyperkinetic movement disorders associated with epileptic encephalopathy and intellectual disability are becoming increasingly recognized. Recently, a de novo heterozygous NACC1 (nucleus accumbens‐associated 1) missense variant was described in a patient cohort including one patient with a combined mitochondrial
Jonna Komulainen‐Ebrahim   +11 more
wiley   +1 more source

Studies of cerebral palsy in the childhood population of Edinburgh [PDF]

open access: yes, 1961
This thesis is the result of an investigation of the prevalence, clinical findings and aetiology of cerebral palsy in the childhood population of Edinburgh which was carried out during 1952 and 1953, whilst the author held a George Guthrie Research ...
Ingram, T. T. S.
core  

The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency

open access: yesJournal of Inherited Metabolic Disease, Volume 47, Issue 3, Page 447-462, May 2024.
Abstract The objective of the study is to evaluate the evolving phenotype and genetic spectrum of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD) in long‐term follow‐up. Longitudinal clinical and biochemical data of 22 pediatric and 9 adult individuals with SSADHD from the patient registry of the International Working Group on ...
Natalia Alexandra Julia‐Palacios   +21 more
wiley   +1 more source

Biomechanical analysis of countermovement jump in people with cerebral palsy

open access: yesEuropean Journal of Human Movement, 2010
The main purpose of the study was to evaluate the patterns of the developed ground reaction forces in the two – legged countermovement jumping, performed by persons affected by tetraparesis with ataxia, tetraparesis with athetosis, tetraparesis with ...
K. Gianikellis   +3 more
doaj  

Investigation of Unintentional Movement in People with Cerebral Palsy to Improve Computer Target Aquisition [PDF]

open access: yes, 2008
People with Cerebral Palsy (CP) have difficulty using computer pointing devices due to unintentional movement in their upper extremities. Fifty percent of people with CP have impaired arm-hand function which limits their ability to interface with ...
Sibenaller, Sara Marie
core  

Measured energy expenditure of tube-fed patients with severe neurodevelopment disabilities [PDF]

open access: yes, 1999
Objective: To determine measured resting energy expenditure (REE) of nonambulatory tube-fed patients with severe neurological neurodevelopmental disabilities. Methods: Twenty patients were prospectively studied.
Brown, Rex O.   +5 more
core   +2 more sources

Journal of the Allentown Hospital [PDF]

open access: yes, 1952
https://scholarlyworks.lvhn.org/allentown-hospital-journal/1006/thumbnail ...
Lehigh Valley Health Network
core   +2 more sources

The effect of Symmetrel (Amantadine hydrochloride) on a case of Athetosis [PDF]

open access: yes, 2018
The results of a double-blind cross-over trial comparing Symmetrel against placebo in a child suffering from severe athetosis are presented. No major benefit is claimed as a result of the administration of Symmetrel.
Hatchuel, w. L. F.
core   +1 more source

Home - About - Disclaimer - Privacy